Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,000 | 3 | 64.6% |
| Food and Beverage | $2,147 | 72 | 34.7% |
| Education | $26.73 | 1 | 0.4% |
| Travel and Lodging | $21.60 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LivaNova USA, Inc. | $2,522 | 4 | $0 (2017) |
| Cyberonics, Inc. | $1,627 | 2 | $0 (2017) |
| Boston Scientific Corporation | $597.97 | 21 | $0 (2020) |
| Abbott Laboratories | $220.38 | 2 | $0 (2020) |
| Medtronic USA, Inc. | $178.27 | 1 | $0 (2019) |
| Amgen Inc. | $171.04 | 5 | $0 (2019) |
| Bardy Diagnostics, Inc. | $140.00 | 2 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $88.39 | 7 | $0 (2018) |
| UCB, Inc. | $84.02 | 6 | $0 (2023) |
| ABBVIE INC. | $80.52 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $371.49 | 18 | Lilly USA, LLC ($54.61) |
| 2023 | $112.61 | 4 | Nevro Corp. ($29.99) |
| 2022 | $18.89 | 1 | ACADIA Pharmaceuticals Inc ($18.89) |
| 2020 | $172.47 | 6 | Abbott Laboratories ($95.38) |
| 2019 | $749.63 | 21 | Boston Scientific Corporation ($271.45) |
| 2018 | $367.14 | 11 | BOSTON SCIENTIFIC CORPORATION ($281.31) |
| 2017 | $4,404 | 17 | LivaNova USA, Inc. ($2,522) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $21.31 | General |
| Category: Sleep Apnea testing | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $16.19 | General |
| 11/19/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Immunology | ||||||
| 10/25/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | — | Food and Beverage | In-kind items and services | $13.82 | General |
| 10/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/15/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Neuroscience | ||||||
| 10/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Rare Disease | ||||||
| 09/27/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Neuroscience | ||||||
| 09/19/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Genetic Disease | ||||||
| 08/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/06/2024 | Eisai Inc. | Leqembi (Drug) | Education | Cash or cash equivalent | $26.73 | General |
| Category: Neurology | ||||||
| 10/25/2023 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Neurology | ||||||
| 07/27/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $28.14 | General |
| 06/20/2023 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $29.99 | General |
| Category: Spinal Cord Stimulator | ||||||
| 02/02/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/30/2020 | Abbott Laboratories | Infinity DBS Pulse Generators (Device) | Food and Beverage | In-kind items and services | $95.38 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/04/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: STRUCTURAL HEART | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 220 | 237 | $41,825 | $14,689 |
| 2022 | 4 | 98 | 101 | $13,996 | $4,448 |
| 2021 | 15 | 666 | 823 | $241,184 | $65,433 |
| 2020 | 13 | 741 | 873 | $261,847 | $68,023 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 108 | 116 | $10,927 | $5,041 | 46.1% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 19 | 23 | $9,493 | $3,666 | 38.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 26 | 26 | $7,046 | $2,337 | 33.2% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 11 | 11 | $3,157 | $1,134 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 23 | 27 | $5,792 | $1,086 | 18.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 17 | 17 | $3,774 | $967.95 | 25.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 16 | 17 | $1,635 | $455.91 | 27.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 37 | 39 | $3,674 | $1,718 | 46.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 12 | 12 | $3,167 | $1,189 | 37.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 17 | 17 | $1,601 | $709.12 | 44.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 13 | $1,973 | $619.36 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 20 | 20 | $3,580 | $212.58 | 5.9% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 46 | 86 | $51,256 | $13,788 | 26.9% |
| 95708 | Measurement of brain wave activity (eeg), 12-26 hours, unmonitored | Office | 2021 | 36 | 69 | $20,769 | $8,228 | 39.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 123 | $22,103 | $8,191 | 37.1% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 167 | 179 | $53,521 | $8,182 | 15.3% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Office | 2021 | 21 | 21 | $13,650 | $5,956 | 43.6% |
| 95721 | Continuous measurement of brain wave activity (eeg), 37-60 hours, with health care professional analysis, interpretation and report | Office | 2021 | 23 | 23 | $10,028 | $3,700 | 36.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 17 | 17 | $8,534 | $2,702 | 31.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 26 | 30 | $5,220 | $2,459 | 47.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 58 | 69 | $3,933 | $2,246 | 57.1% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 19 | 20 | $7,720 | $2,144 | 27.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 49 | 61 | $6,527 | $2,138 | 32.8% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 40 | 41 | $14,427 | $1,854 | 12.9% |
| 95822 | Measurement and recording of brain wave (eeg) activity, in coma or asleep | Facility | 2021 | 28 | 33 | $10,230 | $1,517 | 14.8% |
About Dr. Rajinder Singh, D.O
Dr. Rajinder Singh, D.O is a Epilepsy healthcare provider based in Columbus, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1750506457.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rajinder Singh, D.O has received a total of $6,196 in payments from pharmaceutical and medical device companies, with $371.49 received in 2024. These payments were reported across 78 transactions from 26 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($4,000).
As a Medicare-enrolled provider, Singh has provided services to 1,725 Medicare beneficiaries, totaling 2,034 services with total Medicare billing of $152,592. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Epilepsy
- Other Specialties Neurology
- Location Columbus, IN
- Active Since 04/16/2007
- Last Updated 08/28/2025
- Taxonomy Code 2084E0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1750506457
Products in Payments
- VNS Therapy (Device) $4,149
- WATCHMAN (Device) $597.97
- ACTIVA (Device) $178.27
- Carnation Ambulatory Monitor (Device) $140.00
- Aimovig (Biological) $134.38
- Supera peripheral stent system (Device) $125.00
- Infinity DBS Pulse Generators (Device) $95.38
- APTIOM (Drug) $88.39
- Briviact (Drug) $57.58
- NUPLAZID (Drug) $54.33
- UBRELVY (Drug) $52.48
- EMGALITY (Drug) $38.06
- VYVGART (Drug) $36.12
- ONFI (Drug) $33.17
- Senza (Device) $29.99
- DUOPA (Drug) $28.04
- ONPATTRO (Drug) $27.96
- Leqembi (Drug) $26.73
- Nayzilam (Drug) $26.44
- HYQVIA (Biological) $24.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Epilepsy Doctors in Columbus
Dr. Jason Bisping, M.d, M.D
Epilepsy — Payments: $412,245
Dr. Maryam Mian, Md, MD
Epilepsy — Payments: $1,280
Krithiga Hasbrook, M.d., Phd, M.D., PHD
Epilepsy — Payments: $654.62
Sarita Maturu, D.o, D.O
Epilepsy — Payments: $388.08
Dr. Jesse Mindel, M.d, M.D
Epilepsy — Payments: $16.72